CALICETI, PAOLO
 Distribuzione geografica
Continente #
NA - Nord America 17.168
AS - Asia 3.646
EU - Europa 2.807
SA - Sud America 607
AF - Africa 87
OC - Oceania 16
Continente sconosciuto - Info sul continente non disponibili 6
Totale 24.337
Nazione #
US - Stati Uniti d'America 17.093
SG - Singapore 1.524
CN - Cina 1.012
IT - Italia 738
HK - Hong Kong 715
BR - Brasile 552
FI - Finlandia 446
DE - Germania 331
UA - Ucraina 234
FR - Francia 208
RU - Federazione Russa 169
SE - Svezia 167
GB - Regno Unito 141
PL - Polonia 117
VN - Vietnam 110
NL - Olanda 93
IN - India 54
IR - Iran 43
IE - Irlanda 40
CA - Canada 29
PK - Pakistan 29
ES - Italia 24
TR - Turchia 24
AT - Austria 22
KR - Corea 20
IL - Israele 17
BD - Bangladesh 15
CI - Costa d'Avorio 15
IQ - Iraq 15
SA - Arabia Saudita 14
AR - Argentina 12
BE - Belgio 10
CO - Colombia 10
EC - Ecuador 10
JM - Giamaica 10
GR - Grecia 9
JP - Giappone 9
MA - Marocco 9
PT - Portogallo 9
ZA - Sudafrica 9
AU - Australia 8
VE - Venezuela 8
MX - Messico 7
SI - Slovenia 7
BG - Bulgaria 6
CH - Svizzera 6
DZ - Algeria 6
ID - Indonesia 6
NZ - Nuova Zelanda 6
UZ - Uzbekistan 6
KE - Kenya 5
MY - Malesia 5
TT - Trinidad e Tobago 5
CR - Costa Rica 4
EG - Egitto 4
HN - Honduras 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AZ - Azerbaigian 3
BO - Bolivia 3
CD - Congo 3
CL - Cile 3
GN - Guinea 3
LT - Lituania 3
NO - Norvegia 3
NP - Nepal 3
RO - Romania 3
SN - Senegal 3
UY - Uruguay 3
AD - Andorra 2
AE - Emirati Arabi Uniti 2
AM - Armenia 2
AO - Angola 2
BB - Barbados 2
BJ - Benin 2
BS - Bahamas 2
BY - Bielorussia 2
CM - Camerun 2
CW - ???statistics.table.value.countryCode.CW??? 2
DK - Danimarca 2
DM - Dominica 2
ET - Etiopia 2
GA - Gabon 2
GF - Guiana Francese 2
GH - Ghana 2
HR - Croazia 2
KG - Kirghizistan 2
LB - Libano 2
ME - Montenegro 2
MU - Mauritius 2
NI - Nicaragua 2
PA - Panama 2
PE - Perù 2
PY - Paraguay 2
RS - Serbia 2
SD - Sudan 2
TN - Tunisia 2
TW - Taiwan 2
YT - Mayotte 2
AL - Albania 1
BA - Bosnia-Erzegovina 1
Totale 24.299
Città #
Fairfield 2.213
Woodbridge 2.011
Houston 1.497
Ann Arbor 1.453
Chandler 1.396
Jacksonville 1.144
Ashburn 964
Wilmington 843
Singapore 815
Seattle 759
Cambridge 731
Hong Kong 714
Boardman 424
Princeton 416
Santa Clara 416
San Diego 264
Beijing 228
Padova 218
Medford 201
Nanjing 175
Helsinki 157
Bytom 107
Dong Ket 107
Des Moines 95
Roxbury 80
Guangzhou 60
Hebei 60
Milan 58
Nanchang 56
Shenyang 55
Norwalk 43
São Paulo 39
Changsha 37
Dublin 37
Jinan 37
New York 36
London 35
Munich 35
Jiaxing 33
Tianjin 30
Karachi 20
Rio de Janeiro 19
Lauterbourg 18
Rome 17
Turku 17
Dearborn 16
Falls Church 16
Shanghai 16
Abidjan 15
Indiana 15
Ogden 14
Pohang 14
Tel Aviv 14
Hangzhou 13
Redwood City 13
Campobasso 12
Kharkiv 12
Kilburn 12
Tappahannock 12
Belo Horizonte 11
Bologna 11
L’Aquila 11
Borås 10
Brasília 10
Falkenstein 10
Guarulhos 10
Los Angeles 10
Nuremberg 10
Chicago 9
Porto Alegre 9
Zhengzhou 9
Atlanta 8
Barcelona 8
Brooklyn 8
Campinas 8
Dallas 8
Detroit 8
Fortaleza 8
Ningbo 8
Phoenix 8
Riyadh 8
San Francisco 8
Bangalore 7
Citta Sant'angelo 7
Dhaka 7
Fossò 7
Hefei 7
Kingston 7
Lappeenranta 7
Rockville 7
Vicenza 7
Warsaw 7
Baghdad 6
Charlotte 6
Garbagnate Monastero 6
Juiz de Fora 6
Kunming 6
Napoli 6
Osasco 6
Portsmouth 6
Totale 18.690
Nome #
1H-NMR metabolomics reveals the Glabrescione B exacerbation of glycolytic metabolism beside the cell growth inhibitory effect in glioma 198
Oligo-guanidyl targeted bioconjugates forming rod shaped polyplexes as a new nanoplatform for oligonucleotide delivery 178
A comparative study of folate receptor-targeted doxorubicin delivery systems: Dosing regimens and therapeutic index 167
Switching of macromolecular ligand display by thermoresponsive polymers mediates endocytosis of multi-conjugate nanoparticles 158
Polyethylene glycol-superoxide dismutase, a conjugate in search of exploitation 157
New comprehensive studies of a gold(III) Dithiocarbamate complex with proven anticancer properties: Aqueous dissolution with cyclodextrins, pharmacokinetics and upstream inhibition of the ubiquitin-proteasome pathway 155
Real-Time Label-Free Targeting Assessment and in Vitro Characterization of Curcumin-Loaded Poly-lactic-co-glycolic Acid Nanoparticles for Oral Colon Targeting 148
Nanovectors Design for Theranostic Applications in Colorectal Cancer 146
Control of targeting ligand display by pH-responsive polymers on gold nanoparticles mediates selective entry into cancer cells 141
A NEW PRODUCTION METHOD OF HIGH SPECIFIC ACTIVITY RADIONUCLIDES TOWARDS INNOVATIVE RADIOPHARMACEUTICALS: THE ISOLPHARM PROJECT 140
A novel soluble supramolecular system for sustained rh-GH delivery 140
Novel Oligo-Guanidyl-PEG Carrier Forming Rod-Shaped Polyplexes 139
Polyphosphazene membranes and microspheres in periodontal diseases and implant surgery 138
Site-selective protein glycation and PEGylation 137
Physical PEGylation to Prevent Insulin Fibrillation 135
A branched monomethoxypoly(ethylene glycol) for protein modification 134
PH-Controlled Liposomes for Enhanced Cell Penetration in Tumor Environment 134
Accurate evaluation method of the polymer content in Monomethoxy(polyethylene glycol) modified proteins based on Amino acid analysis 133
Re-programming pullulan for targeting and controlled release of doxorubicin to the hepatocellular carcinoma cells 132
Mucoadhesive thiolated chitosans as platforms for oral controlled drug delivery: synthesis and in vitro evaluation 131
Modified hyaluronic acid derivatives and use thereof 130
Biopharmaceutical properties of uricase conjugated to neutral and amphiphilic polymers 130
Triblock copolymer nanovesicles for pH-responsive targeted delivery and controlled release of siRNA to cancer cells 128
Thermodynamic analysis of micronization processes from gas-saturated solution 126
Preparation and characterization of active site protected poly(ethylene glycol)-avidin bioconjugates 126
Cell up-take control of gold nanoparticles functionalized with a thermoresponsive polymer 126
Immunological properties of uricase conjugated to neutral soluble polymers 126
Self-assembling nanocomposites for protein delivery: Supramolecular interactions between PEG-cholane and rh-G-CSF. 125
Physico-Chemical and Biological Properties of Monofunctional Hydroxy Teriminating Poly(N-Vinylpyrrolidone) Conjugated Superoxide Dismutase 123
Design, synthesis, and photophysical properties of pyrroloquinoline-based compounds showing strong blue fluorescence as potential dyes for biomedical applications 123
A novel combined strategy for the physical PEGylation of polypeptides 123
Preservation of thrombolytic activity of urokinase modified with monomethoxypoly(ethylene glycol) 122
Development and in vivo evaluation of an oral insulin-PEG delivery system 122
Polysaccharide based anticancer prodrugs 122
Production of Lipid Microparticles Containing bioactive molecules Functionalized with PEG 122
Glycosilated macromolecular conjugates of antiviral drugs with a polyaspartamide 122
Recellularized colorectal cancer patient-derived scaffolds as in vitro pre-clinical 3D model for drug screening 122
Novel Pullulan Bioconjugate for Selective Breast Cancer Bone Metastases Treatment 121
Enhanced selective sonosensitizing efficacy of ultrasound-based anticancer treatment by targeted gold nanoparticles 121
Biopharmaceutical characterisation of insulin and recombinant human growth hormone loaded lipid submicron particles produced by supercritical gas micro-atomisation 121
Pretargeted adjuvant radioimmunotherapy with Yttrium-90-biotin in malignant glioma patients: A pilot study 120
Covalent modification of mushroom tyrosinase with different amphiphic polymers for pharmaceutical and biocatalysis applications 120
Production of solid lipid submicron particles for protein delivery using a novel supercritical gas-assisted melting atomization process 120
Therapeutic proteins: a comparison of chemical and biological properties of uricase conjugated to linear or branched poly(ethylene glycol) and poly(N-acryloylmorpholine) 119
Cyclodextrin/PEG based hydrogels for multi-drug delivery. 118
A new site-specific monoPEGylated filgrastim derivative prepared by enzymatic conjugation: Production and physicochemical characterization. 118
Bassi polimeri dell'N-acriloil morfolina monofunzionalizzati ad un estremo per la preparazione di coniugati con enzimi, polipeptidi e farmaci 117
New synthetic polymers for enzyme and liposome modification 117
Preparation, physico-chemical and pharmacokinetic characterization of monomethoxypoly(ethylene glycol)-derivatized superoxide dismutase 116
Curcumin-loaded solid lipid particles by PGSS technology 116
Novel folated and non-folated pullulan bioconjugates for anticancer drug delivery 115
Modification of physico-chemical and biopharmaceutical properties of superoxide dismutase by conjugation to the co-polymer of divinyl ether and maleic anhydride 114
pH-responsive lipid core micelles for tumour targeting 114
Supramolecular Bioconjugates for Protein and Small Drug Delivery. 113
Absorption and metabolism of resveratrol carboxyesters and methanesulfonate by explanted reat intestinal segments 112
In vitro and in vivo behavior of liposomes decorated with PEGs with different chemical features 112
Avidin bioconjugate with a thermoresponsive polymer for biological and pharmaceutical applications 111
Proteins conjugation with ZnO sol-gel nanopowders 111
Control of peptide aggregation and fibrillation by physical PEGylation 111
Anti-inflammatory activity of monomethoxypolyethylene glycol superoxide dismutase on adjuvant arthritis in rats. 110
A once-a-day dosage form for the delivery of insulin through the nasal route: in vitro assessment and in vivo evaluation 109
Enhanced biocopmpatibility of polyphosphazenes achieved by radiation grafting 108
A Method to maintain the activity in polyethylene glycol-modified proteolytic enzymes 106
Targeted Delivery of Small and Macromolecular Drugs 105
Biopolymeric modification of superoxide dismutase (mPEG-SOD) to prevent muscular ischemia-reperfusion damage 105
Synthesis and characterization of variable conformation pH responsive block co-polymers for nucleic acid delivery and targeted cell entry 105
Histaminase PEGylation: Preparation and characterization of a new bioconjugate for therapeutic application 104
Improvement of pharmacokinetic, immunological and stability properties of asparaginase by conjugation to linear and branched monomethoxy poly(ethylene glycol) 104
A novel performing PEG-cholane nanoformulation for Amphotericin B delivery 104
POLY(HYDROXYETHYLASPARTAMIDE) DERIVATIVES AS COLLOIDAL DRUG CARRIER SYSTEMS 104
Fast atom bombardment in the structural identification of intermediates in the hydrolytic degradation of polyphosphazenes 103
New cyclodextrin bioconjugates for active tumour targeting 103
Star-like oligo-arginyl-maltotriosyl derivatives as novel cell-penetrating enhancers for the intracellular delivery of colloidal therapeutic systems 103
Tailored PEG for rh-G-CSF analogue site-specific conjugation. 103
Immunogenic and tolerogenic properties of monomethoxypoly(ethylene glycol) conjugated proteins 102
Pharmacokinetic and biodistribution properties of poly(ethylene glycol)-protein conjugates 102
Sub-unit vaccine against S. aureus-mediated infections: Set-up of nano-sized polymeric adjuvant. 102
pH-sensitive PEG-based micelles for tumor targeting 102
Functionalized polymers to target SerpinB3 in hepatoma cells 101
Arginase Immobilization on Poly(hydroxyethyl acrylate) Matrix Beads 100
Branched and linear poly(ethylene glycol): Influence of the polymer structure on enzymological, pharmacokinetic, and immunological properties of protein conjugates 99
A comparative study of enzymatic, structural, and pharmacokinetic properties of superoxide dismutase isolated from two sources and modified by monomethoxypolyethylene glycol using different methods of coupling. 99
Dexamethasone loaded liposomes by thin‐film hydration and microfluidic procedures: Formulation challenges 99
Biochemical modifications of avidin improve pharmacokinetics and biodistribution, and reduce immunogenicity 98
Advances in drug delivery and biomaterials: Facts and vision 98
Supramolecular association of recombinant human growth hormone with hydrophobized polyhydroxyethylaspartamides 98
Active Site Protection of Proteolytic Enzymes by Poly(ethylene glycol) Surface Modification 97
Nanotechnologies in protein delivery. 97
In vitro and in vivo evaluation of an oral multiple-unit formulation for colonic delivery of insulin 97
Custom-tailored pharmacokinetics and pharmacodynamics via chemical modifications of biotech drugs 97
Bioconjugation and biodistribution 96
Nisin-loaded poly-L-lactide nano-particles produced by CO2 anti-solvent precipitation for sustained antimicrobial activity. 96
Synthesis and molecular weight characterization of low molecular weight end-functionalized poly(4-acryloylmorpholine) 96
Radiation-induced graft copolymerization of hydrophilic monomers onto polyphosphazenes 96
Thermosensitive "Smart" Surfaces for Biorecognition Based Cell Adhesion and Controlled Detachment 96
Polyphosphazene microspheres for insulin delivery 95
Recent Advances in Understanding the Protein Corona of Nanoparticles and in the Formulation of “Stealthy” Nanomaterials 94
Specific antitumor targetable beta-cyclodextrin-poly(ethylene glycol)-folic acid drug delivery bioconjugate. 93
End functionalized PVP as new oligomer for enzyme modification 93
Poly (acryloyl-l-proline methyl ester) hydrogels obtained by radiation polymerization for the controlled release of drugs 93
Totale 11.728
Categoria #
all - tutte 86.954
article - articoli 65.022
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 3.654
selected - selezionate 0
volume - volumi 3.037
Totale 158.667


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020201 0 0 0 0 0 0 0 0 0 0 0 201
2020/20212.733 113 188 64 231 184 278 139 249 432 297 341 217
2021/20223.173 77 523 411 157 150 141 119 370 158 96 374 597
2022/20232.743 585 271 96 294 467 303 7 209 313 26 125 47
2023/20241.254 50 215 143 92 65 58 103 77 41 48 171 191
2024/20255.401 33 306 291 193 924 183 272 387 553 222 911 1.126
Totale 24.530